[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global RNA-Based Vaccines Sales Market Report 2017

August 2017 | 113 pages | ID: GEDEFEAA024EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global RNA-Based Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of RNA-Based Vaccines for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global RNA-Based Vaccines market competition by top manufacturers/players, with RNA-Based Vaccines sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Abbott Laboratories
  • Arrowhead Pharmaceuticals
  • Benitec Biopharma
  • Calimmune Inc
  • Dicerna
  • Gradalis
  • Quark
  • RXi
  • Senesco
  • Silence Therapeutics
  • Silenseed
  • Tekmira
  • Alnylam Pharmaceuticals
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Type I
  • Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of RNA-Based Vaccines for each application, including
  • Cancer
  • Diabetes
  • Tuberculosis
  • Cardiovascular Diseases
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global RNA-Based Vaccines Sales Market Report 2017

1 RNA-BASED VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of RNA-Based Vaccines
1.2 Classification of RNA-Based Vaccines by Product Category
  1.2.1 Global RNA-Based Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global RNA-Based Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Type I
  1.2.4 Type II
1.3 Global RNA-Based Vaccines Market by Application/End Users
  1.3.1 Global RNA-Based Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 Global RNA-Based Vaccines Market by Region
  1.4.1 Global RNA-Based Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.3 China RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.4 Europe RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.5 Japan RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.6 Southeast Asia RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.7 India RNA-Based Vaccines Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of RNA-Based Vaccines (2012-2022)
  1.5.1 Global RNA-Based Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 Global RNA-Based Vaccines Revenue and Growth Rate (2012-2022)

2 GLOBAL RNA-BASED VACCINES COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global RNA-Based Vaccines Market Competition by Players/Suppliers
  2.1.1 Global RNA-Based Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global RNA-Based Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global RNA-Based Vaccines (Volume and Value) by Type
  2.2.1 Global RNA-Based Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 Global RNA-Based Vaccines Revenue and Market Share by Type (2012-2017)
2.3 Global RNA-Based Vaccines (Volume and Value) by Region
  2.3.1 Global RNA-Based Vaccines Sales and Market Share by Region (2012-2017)
  2.3.2 Global RNA-Based Vaccines Revenue and Market Share by Region (2012-2017)
2.4 Global RNA-Based Vaccines (Volume) by Application

3 UNITED STATES RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 United States RNA-Based Vaccines Sales and Value (2012-2017)
  3.1.1 United States RNA-Based Vaccines Sales and Growth Rate (2012-2017)
  3.1.2 United States RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  3.1.3 United States RNA-Based Vaccines Sales Price Trend (2012-2017)
3.2 United States RNA-Based Vaccines Sales Volume and Market Share by Players
3.3 United States RNA-Based Vaccines Sales Volume and Market Share by Type
3.4 United States RNA-Based Vaccines Sales Volume and Market Share by Application

4 CHINA RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 China RNA-Based Vaccines Sales and Value (2012-2017)
  4.1.1 China RNA-Based Vaccines Sales and Growth Rate (2012-2017)
  4.1.2 China RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  4.1.3 China RNA-Based Vaccines Sales Price Trend (2012-2017)
4.2 China RNA-Based Vaccines Sales Volume and Market Share by Players
4.3 China RNA-Based Vaccines Sales Volume and Market Share by Type
4.4 China RNA-Based Vaccines Sales Volume and Market Share by Application

5 EUROPE RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 Europe RNA-Based Vaccines Sales and Value (2012-2017)
  5.1.1 Europe RNA-Based Vaccines Sales and Growth Rate (2012-2017)
  5.1.2 Europe RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  5.1.3 Europe RNA-Based Vaccines Sales Price Trend (2012-2017)
5.2 Europe RNA-Based Vaccines Sales Volume and Market Share by Players
5.3 Europe RNA-Based Vaccines Sales Volume and Market Share by Type
5.4 Europe RNA-Based Vaccines Sales Volume and Market Share by Application

6 JAPAN RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Japan RNA-Based Vaccines Sales and Value (2012-2017)
  6.1.1 Japan RNA-Based Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 Japan RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Japan RNA-Based Vaccines Sales Price Trend (2012-2017)
6.2 Japan RNA-Based Vaccines Sales Volume and Market Share by Players
6.3 Japan RNA-Based Vaccines Sales Volume and Market Share by Type
6.4 Japan RNA-Based Vaccines Sales Volume and Market Share by Application

7 SOUTHEAST ASIA RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia RNA-Based Vaccines Sales and Value (2012-2017)
  7.1.1 Southeast Asia RNA-Based Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia RNA-Based Vaccines Sales Price Trend (2012-2017)
7.2 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Players
7.3 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Type
7.4 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Application

8 INDIA RNA-BASED VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 India RNA-Based Vaccines Sales and Value (2012-2017)
  8.1.1 India RNA-Based Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 India RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 India RNA-Based Vaccines Sales Price Trend (2012-2017)
8.2 India RNA-Based Vaccines Sales Volume and Market Share by Players
8.3 India RNA-Based Vaccines Sales Volume and Market Share by Type
8.4 India RNA-Based Vaccines Sales Volume and Market Share by Application

9 GLOBAL RNA-BASED VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 RNA-Based Vaccines Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Pfizer RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Roche
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 RNA-Based Vaccines Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Roche RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Sanofi-Aventis
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 RNA-Based Vaccines Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Sanofi-Aventis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Abbott Laboratories
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 RNA-Based Vaccines Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Abbott Laboratories RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Arrowhead Pharmaceuticals
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 RNA-Based Vaccines Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Benitec Biopharma
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 RNA-Based Vaccines Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Benitec Biopharma RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Calimmune Inc
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 RNA-Based Vaccines Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Calimmune Inc RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Dicerna
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 RNA-Based Vaccines Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Dicerna RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Gradalis
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 RNA-Based Vaccines Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Gradalis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Quark
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 RNA-Based Vaccines Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Quark RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 RXi
9.12 Senesco
9.13 Silence Therapeutics
9.14 Silenseed
9.15 Tekmira
9.16 Alnylam Pharmaceuticals

10 RNA-BASED VACCINES MAUFACTURING COST ANALYSIS

10.1 RNA-Based Vaccines Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of RNA-Based Vaccines
10.3 Manufacturing Process Analysis of RNA-Based Vaccines

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 RNA-Based Vaccines Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of RNA-Based Vaccines Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL RNA-BASED VACCINES MARKET FORECAST (2017-2022)

14.1 Global RNA-Based Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global RNA-Based Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global RNA-Based Vaccines Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global RNA-Based Vaccines Price and Trend Forecast (2017-2022)
14.2 Global RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global RNA-Based Vaccines Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global RNA-Based Vaccines Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global RNA-Based Vaccines Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global RNA-Based Vaccines Sales Forecast by Type (2017-2022)
  14.3.2 Global RNA-Based Vaccines Revenue Forecast by Type (2017-2022)
  14.3.3 Global RNA-Based Vaccines Price Forecast by Type (2017-2022)
14.4 Global RNA-Based Vaccines Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of RNA-Based Vaccines
Figure Global RNA-Based Vaccines Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global RNA-Based Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure Global RNA-Based Vaccines Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of RNA-Based Vaccines by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global RNA-Based Vaccines Market Size (Million USD) by Regions (2012-2022)
Figure United States RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure China RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global RNA-Based Vaccines Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players RNA-Based Vaccines Sales Volume (K Units) (2012-2017)
Table Global RNA-Based Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global RNA-Based Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 RNA-Based Vaccines Sales Share by Players/Suppliers
Figure 2017 RNA-Based Vaccines Sales Share by Players/Suppliers
Figure Global RNA-Based Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global RNA-Based Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global RNA-Based Vaccines Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global RNA-Based Vaccines Revenue Share by Players
Table 2017 Global RNA-Based Vaccines Revenue Share by Players
Table Global RNA-Based Vaccines Sales (K Units) and Market Share by Type (2012-2017)
Table Global RNA-Based Vaccines Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of RNA-Based Vaccines by Type (2012-2017)
Figure Global RNA-Based Vaccines Sales Growth Rate by Type (2012-2017)
Table Global RNA-Based Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global RNA-Based Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA-Based Vaccines by Type (2012-2017)
Figure Global RNA-Based Vaccines Revenue Growth Rate by Type (2012-2017)
Table Global RNA-Based Vaccines Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global RNA-Based Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of RNA-Based Vaccines by Region (2012-2017)
Figure Global RNA-Based Vaccines Sales Growth Rate by Region in 2016
Table Global RNA-Based Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global RNA-Based Vaccines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of RNA-Based Vaccines by Region (2012-2017)
Figure Global RNA-Based Vaccines Revenue Growth Rate by Region in 2016
Table Global RNA-Based Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global RNA-Based Vaccines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of RNA-Based Vaccines by Region (2012-2017)
Figure Global RNA-Based Vaccines Revenue Market Share by Region in 2016
Table Global RNA-Based Vaccines Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global RNA-Based Vaccines Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of RNA-Based Vaccines by Application (2012-2017)
Figure Global RNA-Based Vaccines Sales Market Share by Application (2012-2017)
Figure United States RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure United States RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table United States RNA-Based Vaccines Sales Volume (K Units) by Players (2012-2017)
Table United States RNA-Based Vaccines Sales Volume Market Share by Players (2012-2017)
Figure United States RNA-Based Vaccines Sales Volume Market Share by Players in 2016
Table United States RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table United States RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure United States RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table United States RNA-Based Vaccines Sales Volume (K Units) by Application (2012-2017)
Table United States RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure United States RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure China RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure China RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure China RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table China RNA-Based Vaccines Sales Volume (K Units) by Players (2012-2017)
Table China RNA-Based Vaccines Sales Volume Market Share by Players (2012-2017)
Figure China RNA-Based Vaccines Sales Volume Market Share by Players in 2016
Table China RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table China RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure China RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table China RNA-Based Vaccines Sales Volume (K Units) by Application (2012-2017)
Table China RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure China RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure Europe RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Europe RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Europe RNA-Based Vaccines Sales Volume (K Units) by Players (2012-2017)
Table Europe RNA-Based Vaccines Sales Volume Market Share by Players (2012-2017)
Figure Europe RNA-Based Vaccines Sales Volume Market Share by Players in 2016
Table Europe RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Europe RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Europe RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table Europe RNA-Based Vaccines Sales Volume (K Units) by Application (2012-2017)
Table Europe RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Europe RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure Japan RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Japan RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Japan RNA-Based Vaccines Sales Volume (K Units) by Players (2012-2017)
Table Japan RNA-Based Vaccines Sales Volume Market Share by Players (2012-2017)
Figure Japan RNA-Based Vaccines Sales Volume Market Share by Players in 2016
Table Japan RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Japan RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Japan RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table Japan RNA-Based Vaccines Sales Volume (K Units) by Application (2012-2017)
Table Japan RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Japan RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure Southeast Asia RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia RNA-Based Vaccines Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Players in 2016
Table Southeast Asia RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table Southeast Asia RNA-Based Vaccines Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Figure India RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure India RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure India RNA-Based Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table India RNA-Based Vaccines Sales Volume (K Units) by Players (2012-2017)
Table India RNA-Based Vaccines Sales Volume Market Share by Players (2012-2017)
Figure India RNA-Based Vaccines Sales Volume Market Share by Players in 2016
Table India RNA-Based Vaccines Sales Volume (K Units) by Type (2012-2017)
Table India RNA-Based Vaccines Sales Volume Market Share by Type (2012-2017)
Figure India RNA-Based Vaccines Sales Volume Market Share by Type in 2016
Table India RNA-Based Vaccines Sales Volume (K Units) by Application (2012-2017)
Table India RNA-Based Vaccines Sales Volume Market Share by Application (2012-2017)
Figure India RNA-Based Vaccines Sales Volume Market Share by Application in 2016
Table Pfizer Basic Information List
Table Pfizer RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Pfizer RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Pfizer RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Roche RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Roche RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Sanofi-Aventis RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Abbott Laboratories RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Abbott Laboratories RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Arrowhead Pharmaceuticals Basic Information List
Table Arrowhead Pharmaceuticals RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Benitec Biopharma Basic Information List
Table Benitec Biopharma RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Benitec Biopharma RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Benitec Biopharma RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Calimmune Inc Basic Information List
Table Calimmune Inc RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Calimmune Inc RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Calimmune Inc RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Dicerna Basic Information List
Table Dicerna RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Dicerna RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Dicerna RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Gradalis Basic Information List
Table Gradalis RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Gradalis RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Gradalis RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table Quark Basic Information List
Table Quark RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Quark RNA-Based Vaccines Sales Global Market Share (2012-2017
Figure Quark RNA-Based Vaccines Revenue Global Market Share (2012-2017)
Table RXi Basic Information List
Table Senesco Basic Information List
Table Silence Therapeutics Basic Information List
Table Silenseed Basic Information List
Table Tekmira Basic Information List
Table Alnylam Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA-Based Vaccines
Figure Manufacturing Process Analysis of RNA-Based Vaccines
Figure RNA-Based Vaccines Industrial Chain Analysis
Table Raw Materials Sources of RNA-Based Vaccines Major Players in 2016
Table Major Buyers of RNA-Based Vaccines
Table Distributors/Traders List
Figure Global RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global RNA-Based Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global RNA-Based Vaccines Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global RNA-Based Vaccines Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global RNA-Based Vaccines Sales Volume Market Share Forecast by Regions in 2022
Table Global RNA-Based Vaccines Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global RNA-Based Vaccines Revenue Market Share Forecast by Regions (2017-2022)
Figure Global RNA-Based Vaccines Revenue Market Share Forecast by Regions in 2022
Figure United States RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China RNA-Based Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Europe RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global RNA-Based Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure Global RNA-Based Vaccines Sales Volume Market Share Forecast by Type (2017-2022)
Table Global RNA-Based Vaccines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global RNA-Based Vaccines Revenue Market Share Forecast by Type (2017-2022)
Table Global RNA-Based Vaccines Price (USD/Unit) Forecast by Type (2017-2022)
Table Global RNA-Based Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure Global RNA-Based Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories